Theravance Biopharma Inc
NASDAQ:TBPH
Theravance Biopharma Inc
Operating Expenses
Theravance Biopharma Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theravance Biopharma Inc
NASDAQ:TBPH
|
Operating Expenses
-$110.7m
|
CAGR 3-Years
33%
|
CAGR 5-Years
18%
|
CAGR 10-Years
3%
|
See Also
What is Theravance Biopharma Inc's Operating Expenses?
Operating Expenses
-110.7m
USD
Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Operating Expenses amounts to -110.7m USD.
What is Theravance Biopharma Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
3%
Over the last year, the Operating Expenses growth was 15%. The average annual Operating Expenses growth rates for Theravance Biopharma Inc have been 33% over the past three years , 18% over the past five years , and 3% over the past ten years .